13D Filing: Walgreens Boots Alliance, Inc. Discloses Update to Amerisourcebergen Corp (ABC) Holding

Page 3 of 68

Page 3 of 68 SEC Filing


13D

CUSIP No. 03073E105
  1 

Name of
Reporting Person

Walgreens Pharmacy Strategies, LLC

  2

Check the Appropriate Box if a Member
of a Group (See Instructions)

(a)  ¨        (b)  x

  3

SEC Use Only

  4

Source of Funds (See Instructions)

AF, WC

  5

Check box if Disclosure of Legal
Proceedings Is Required Pursuant to Item 2(d) or 2(e)

¨

  6

Citizenship or Place of
Organization

Illinois

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

  7 

Sole Voting Power

  8

Shared Voting Power

34,157,955

  9

Sole Dispositive Power

10

Shared Dispositive Power

34,157,955

11

Aggregate Amount Beneficially Owned by Each Reporting Person

34,157,955

12

Check box if the Aggregate Amount in
Row (11) Excludes Certain Shares (See Instructions)

¨

13

Percent of Class Represented by Amount
in Row (11)

14.96%*

14

Type of Reporting Person (See
Instructions)

OO

* This calculation is based on 205,632,943 shares of Common Stock outstanding as of October 31, 2015 (as reported by the Issuer in its Annual Report on Form 10-K for the fiscal year ended September 30, 2015
filed with the SEC on November 24, 2015), plus the 22,696,912 shares of Common Stock issuable upon the exercise of warrants (Warrant 1) that may be deemed to be beneficially owned by the Reporting Person that are exercisable within 60 days of
the date of this Amendment No. 2, which shares are deemed to be outstanding for the purpose of computing the percentage of outstanding shares beneficially owned by the Reporting Person in accordance with Exchange Act Rule 13d-3(d)(1)(i).

Follow Cencora Inc. (NYSE:COR)

Page 3 of 68